Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma

Oncology Letters

Volumn 5, Issue 5, 2013, Pages 1572-1578

  Guo, Jinghui ^a   Lou, Wenhui ^b   Ji, Yuan ^b   Zhang, Shuncai ^b  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

CCR7; CXCR4; Lymph node metastasis; Pancreatic ductal adenocarcinoma; VEGF C

Indexed keywords

BETA ACTIN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; MESSENGER RNA; VASCULOTROPIN C;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84875725364     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1261     Document Type: Article

References (34)

1. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, QinR, Gullerud RE, Donohue JH, Nagorney DM and Farnell MB: Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247: 456-462, 2008.
2. House MG, Gönen M, Jarnagin WR, et al: Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11: 1549-1555, 2007.
3. Arya M, Patel HR and Williamson M: Chemokines: key players in cancer. Curr Med Res Opin 19: 557-564, 2003.
4. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S and Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188: 373-386, 1998.
5. Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT and Tahara H: CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res 60: 2209-2217, 2000.
6. Murdoch C: CXCR4: chemokine receptor extraordinaire. Immunol Rev 177: 175-184, 2000.
7. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP and Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686, 2003.
8. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, KukkE, Saksela O, Kalkkinen N and Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298, 1996.
9. Orlandini M, Marconcini L, Ferruzzi R and Oliviero S: Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93: 11675-11680, 1996.
10. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M and Alitalo K: Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570, 1995.
11. Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE and Sahin A: CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res 11: 5686-5693, 2005.
12. Günther K, Leier J, Henning G, et al: Predictor of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer 116: 726-733, 2005.
13. Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, KomotoI, Hashimoto Y, Miyake M, Hashida H and ImamuraM: Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 9: 3406-3412, 2003.
14. Heresi GA, Wang J, Taichman R, Chirinos JA, Regalado JJ, Lichtstein DM and Rosenblatt JD: Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression. Urol Oncol 23: 261-267, 2005.
15. Tsuzuki H, Takahashi N, Kojima A, Narita N, Sunaga H, Takabayashi T and Fujieda S: Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses. Auris Nasus Larynx 33: 37-42, 2006.
16. Kato M, Kitayama J, Kazama S and Nagawa H: Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5: R144-R150, 2003.
17. Uchida D, Begum NM, Almofti A, Nakashiro K, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H and Sato M: Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 290: 289-302, 2003.
18. Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W and Hönigschnabl S: Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med32: 455-460, 2003.
19. Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A and Burian M: Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 25: 464-474, 2003.
20. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T and UchidaY: Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 97: 457-464, 2003.
21. Van Trappen PO, Steele D, Lowe DG, Baithun S, BeasleyN, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper MS, Jackson DG, Sleeman JP and Jacobs IJ: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 201: 544 554, 2003.
22. Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA and Fox SB: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 200: 183-194, 2003.
23. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, Ishigami S and Aikou T: CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol 35: 19-24, 2009.
24. Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W and Tan Y: Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J 15: 519-525, 2009.
25. Nakao A, Takeda S, Sakai M, Kaneko T, Inoue S, SugimotoH and Kanazumi N: Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection. Pancreas 28: 289-292, 2004.
26. Büchler MW, Kleeff J and Friess H: Surgical treatment of pancreatic cancer. J Am Coll Surg 205 (4 Suppl): S81-S86, 2007.
27. Koliopanos A, Avgerinos C, Farfaras A, Manes C and DervenisC: Radical resection of pancreatic cancer. Hepatobiliary Pancreat Dis Int 7: 11-18, 2008.
28. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E and Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
29. Nakata B, Fukunaga S, Noda E, Amano R, Yamada N and Hirakawa K: Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology 74: 69-75, 2008.
30. Tang RF, Wang SX, Peng L, Wang SX, Zhang M, Li ZF, ZhangZM, Xiao Y and Zhang FR: Expression of vascular endothelial growth factors A and C in human pancreatic cancer. World J Gastroenterol 12: 280-286, 2006.
31. Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S and Aikou T: Impact of vascular endothelial growth factor-C and-D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res 10: 8413-8420, 2004.
32. Wehler T, Wolfert F, Schimanski CC, Gockel I, Herr W, BiesterfeldS, Seifert JK, Adwan H and Berger MR: Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease. Oncol Rep 16: 1159-1164, 2006.
33. Niu ZX, Fei LM and Wang CL: Expression of CXCL12-CXCR4 and its association with angiogenesis in pancreatic cancer. Zhonghua Zhong Liu Za Zhi 31: 286-287, 2009 (In Chinese).
34. Neel NF, Schutyser E, Sai J, Fan GH and Richmond A: Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev 16: 637-658, 2005.